SEROLOGIC RESPONSE TO ORAL POLIO VACCINE AND ENHANCED-POTENCY INACTIVATED POLIO VACCINES

被引：94
|
作者：
MCBEAN, AM
THOMS, ML
ALBRECHT, P
CUTHIE, JC
BERNIER, R
机构：
[1] US FDA,OFF BIOL RES & REVIEW,BETHESDA,MD 20014
[2] CTR DIS CONTROL,CTR PREVENT SERV,DIV IMMUNIZAT,ATLANTA,GA 30333
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 1988年 / 128卷 / 03期
关键词：
D O I：
10.1093/oxfordjournals.aje.a115009
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：615 / 628
页数：14
相关论文
共 50 条
  • [21] POTENCY TEST OF INACTIVATED POLIO-VACCINES IN GUINEA-PIGS
    LAPINLEIMU, K
    STENVIK, M
    DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION, 1981, 47 : 109 - 112
  • [22] COMBINED IMMUNIZATION PROGRAM OF ORAL POLIO VACCINE (OPV) AND INACTIVATED POLIO VACCINE (IPV) IN THE WEST BANK
    GERICHTER, CB
    HANDSHER, R
    SEVER, I
    GOLDBLUM, N
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1984, 20 (05): : 481 - 481
  • [23] CLINICAL EFFICACY OF A NEW, ENHANCED-POTENCY, INACTIVATED POLIOVIRUS VACCINE
    ROBERTSON, SE
    DRUCKER, JA
    FABRETESTE, B
    NDIAYE, M
    TRAVERSO, HP
    ROVIRA, EZ
    SOW, A
    SY, MTA
    DIOUF, F
    LANCET, 1988, 1 (8591): : 897 - 899
  • [24] India to introduce rubella and rotavirus vaccines and inactivated polio vaccine
    Mudur, Ganapati
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [25] Inactivated polio vaccine recommended
    Pugliese, G
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1996, 17 (03): : 201 - 201
  • [26] Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame
    Gaensbauer, James T.
    Gast, Chris
    Bandyopadhyay, Ananda S.
    O'Ryan, Miguel
    Saez-Llorens, Xavier
    Rivera, Luis
    Lopez-Medina, Eduardo
    Melgar, Mario
    Weldon, William C.
    Oberste, M. Steven
    Ruttimann, Ricardo
    Clemens, Ralf
    Asturias, Edwin J.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 : S57 - S65
  • [27] Changing oral vaccine to inactivated polio vaccine might increase mortality
    Fish, Eleanor N.
    Flanagan, Kate L.
    Furman, David
    Klein, Sabra L.
    Kollmann, Tobias R.
    Jeppesen, Dorthe L.
    Levy, Ofer
    Marchant, Arnaud
    Namachivayam, Siva
    Netea, Mihai G.
    Plebanski, Magdalena
    Rowland-Jones, Sarah L.
    Selin, Liisa K.
    Shann, Frank
    Whittle, Hilton C.
    LANCET, 2016, 387 (10023): : 1054 - 1055
  • [28] The case for replacing live oral polio vaccine with inactivated vaccine in the Americas
    Alfaro-Murillo, Jorge A.
    Avila-Aguero, Maria L.
    Fitzpatrick, Meagan C.
    Crystal, Caroline J.
    Falleiros-Arlant, Luiza-Helena
    Galvani, Alison P.
    LANCET, 2020, 395 (10230): : 1163 - 1166
  • [29] Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines
    Yuting Fu
    Rufei Ma
    Zhimei Zhao
    Zhaojun Mo
    Zhifang Ying
    Jing Li
    Hui Ye
    Guoliang Li
    Xiaochang Liu
    Jiangli Liang
    Ling Ping
    Jingyan Li
    Junhui Tao
    Qinghai Yang
    Dingkai Wei
    Li Yi
    Hongbo Chen
    Jianfeng Wang
    Ruiju Jiang
    Lei Yu
    Wei Cai
    Wei Yang
    Lei Yue
    Mingxue Xie
    Qiongzhou Yin
    Jing Pu
    Chao Hong
    Lukui Cai
    Yan Deng
    Jiana Wen
    Yan Ma
    Na Gao
    Xiaoyu Wang
    Hongwei Liao
    Qiuyan Ji
    Guang Ji
    Wenzhu Hu
    Qin Gu
    Xiaoyue He
    Han Chu
    Yixian Fu
    Jian Zhou
    Yu Wen
    Xiaolei Yang
    Changgui Li
    Li Shi
    Ting Zhao
    Teng Huang
    Jingsi Yang
    npj Vaccines, 10 (1)
  • [30] Maximising the impact of inactivated polio vaccines
    Brickley, Elizabeth B.
    Wright, Peter F.
    LANCET INFECTIOUS DISEASES, 2017, 17 (07): : 680 - 681
12345